DnaNudge

DnaNudge was a British company specializing in DNA testing and genetically informed consumer health products. It was founded in 2015 by Chris Toumazou and was associated with Imperial College London. The company’s proposition centered on using genetic information to provide individuals with personalized guidance, particularly in areas such as nutrition and lifestyle. Its name reflected the intended combination of DNA analysis with small, actionable recommendations, or “nudges.” The company became more widely associated with rapid molecular diagnostics during the COVID-19 pandemic. In late 2020, it introduced COVID Nudge, a rapid RT-PCR testing system designed to process samples in a compact device rather than relying on centralized laboratory infrastructure. The system used a disposable sample capsule, which was placed into a sample processor box. Results were reported in approximately 90 minutes. This format was intended to support faster testing in settings where conventional laboratory turnaround times were impractical. COVID Nudge attracted public-sector attention in the United Kingdom. By August 2020, the British government had ordered 5,000 sample processor boxes, according to the company’s Wikipedia entry. The order represented a significant shift in emphasis from DnaNudge’s earlier consumer-oriented DNA and nutrition proposition toward infectious-disease diagnostics and pandemic response. Sir Richard Sykes joined the company’s board in 2021. His appointment connected DnaNudge with an experienced figure in British life sciences and healthcare leadership, although the available reference material does not provide enough information to describe the full board or management structure. DnaNudge entered administration in 2024. Administration is a formal insolvency process in the United Kingdom and indicates that the company was no longer operating as a going concern in its previous form. The available reference material does not specify the administrator, the company’s creditors, the disposition of its technology, or whether any assets or operations continued under another entity. Consequently, DnaNudge is best classified as a defunct British diagnostics and DNA-testing company, with its most visible late-stage product being the COVID Nudge rapid RT-PCR system.

DnaNudge was founded in 2015 by Chris Toumazou in the United Kingdom. The company was associated with Imperial College London and specialized in DNA testing. Its initial identity was linked to the use of genetic information for personalized recommendations, especially in nutrition and lifestyle contexts. The company’s concept was to turn genetic insights into practical consumer guidance rather than present DNA testing solely as a laboratory service. During the COVID-19 pandemic, DnaNudge expanded into rapid molecular diagnostics. In late 2020, it launched COVID Nudge, a rapid RT-PCR testing system. The system used a disposable sample capsule placed into a dedicated sample processor box and was designed to deliver results in about 90 minutes. This approach sought to shorten the interval between sample collection and result reporting by performing molecular testing in a compact processing environment. The COVID Nudge system received attention from the United Kingdom’s public sector. By August 2020, the British government had ordered 5,000 sample processor boxes. The order placed DnaNudge’s technology within the broader national effort to increase COVID-19 testing capacity and reduce dependence on slower centralized laboratory workflows. In 2021, Sir Richard Sykes joined DnaNudge’s board. The available reference material does not identify the company’s complete executive team, ownership arrangements, commercial partners, or the precise scale of its operations. It also does not establish whether the consumer DNA-testing business continued independently after the company’s move into COVID-19 diagnostics. DnaNudge entered administration in 2024. The available information does not identify the administrator or describe any subsequent sale, restructuring, liquidation, or transfer of intellectual property. The company is therefore treated as defunct, while the continuing status of individual products, patents, or technologies remains unknown.

• 2024

  DnaNudge enters administration

  [1]DnaNudgeen.wikipedia.org

  The company entered administration in the United Kingdom and is treated as defunct.

• 2021

  Sir Richard Sykes joins the board

  [1]DnaNudgeen.wikipedia.org

  Sir Richard Sykes joined DnaNudge’s board.

• 2020

  COVID Nudge is introduced

  [1]DnaNudgeen.wikipedia.org

  The company introduced a rapid RT-PCR testing system using disposable sample capsules and dedicated sample processor boxes.

• 2020

  UK government orders sample processor boxes

  [1]DnaNudgeen.wikipedia.org

  By August, the British government had ordered 5,000 sample processor boxes for the COVID Nudge system.

• 2015

  DnaNudge is founded

  [1]DnaNudgeen.wikipedia.org

  Chris Toumazou founded DnaNudge in the United Kingdom as a company specializing in DNA testing and personalized health guidance.

A British DNA-testing and personalized-health company that later expanded into rapid molecular diagnostics during the COVID-19 pandemic.

• Genetic testing and consumer health · 2015

  DNA testing and personalized nutrition guidance

  DnaNudge’s original business focused on DNA testing and the use of genetic information to provide personalized recommendations, particularly in nutrition and lifestyle. The available reference material does not specify the exact test format, product names, clinical claims, or current availability of these offerings.

• Rapid molecular diagnostics · 2020

  COVID Nudge

  COVID Nudge was a rapid RT-PCR testing system introduced during the COVID-19 pandemic. It used a disposable sample capsule inserted into a sample processor box and was designed to produce results in approximately 90 minutes. The system was aimed at providing faster molecular testing outside conventional centralized laboratory workflows.

• 2024

  Entry into administrationOther

  Background

  DnaNudge entered a formal United Kingdom insolvency process.

  Action taken

  The company went into administration.

  Aftermath

  The company is classified as defunct. Details of any asset sale, restructuring, or successor operations are not available in the reference material.

  Source

• 2020

  Expansion into rapid COVID-19 molecular diagnosticsProduct launch

  Background

  The COVID-19 pandemic created demand for faster testing and more distributed diagnostic capacity.

  Action taken

  DnaNudge introduced COVID Nudge, a rapid RT-PCR system based on disposable sample capsules and dedicated processor boxes.

  Aftermath

  The system received public-sector attention, and the British government had ordered 5,000 sample processor boxes by August 2020.

  Source

1. 1DnaNudgeen.wikipedia.org